RecruitingPhase 3NCT07228832
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Sponsor: Summit Therapeutics
Camden, NJ · New Brunswick, NJ · +110 more sites
2 recruiting colorectal cancer studies with a site in Camden, NJ.
Sponsor: Summit Therapeutics
Camden, NJ · New Brunswick, NJ · +110 more sites
Sponsor: M.D. Anderson Cancer Center
Camden, NJ · +9 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.